Palomar (PLMR) Stock Price, News & Analysis

Company Overview

Palomar Holdings, Inc. (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels. The Specialty Program Management segment offers third-party administration, captive insurance solutions and technology-driven services such as claims adjudication, network access and wellness program integration, helping clients manage costs, enhance plan performance and support employee health initiatives.

Headquartered in Chicago, Illinois, Palomar serves a diverse range of mid-market and large employer groups across all 50 states. The company leverages a national distribution network of independent brokers, wholesale agencies and benefits consultants, combined with proprietary data analytics and underwriting platforms, to design and deliver customized solutions that meet the specific risk profiles and financial objectives of its clients.

Since launching operations, Palomar has expanded its capabilities to include cell captive arrangements and pooled coverage programs, reflecting a commitment to innovation in specialty risk financing. The company’s leadership team is composed of seasoned insurance executives with extensive experience in underwriting, claims management and program administration, underscoring Palomar’s focus on disciplined risk selection and service excellence.

Key Stats

• Today's Range: $113.36 to $115.83
• 50-Day Range: $108.16 to $133.72
• 52-Week Range: $107.51 to $175.85
• Volume: 172,300 shs
• Average Volume: 300,491 shs
• Market Capitalization: $3.02 billion
• P/E Ratio: 15.86
• Dividend Yield: N/A
• Price Target: $150.25
• Consensus Rating: Moderate Buy

Palomar Stock Analysis - MarketRank™

Palomar scored higher than 90% of companies evaluated by MarketBeat, and ranked 141st out of 880 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Palomar has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

Palomar has a consensus price target of $150.25, representing about 31.9% upside from its current price of $113.87.

Amount of Analyst Coverage

Palomar has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 15.63%

Earnings Growth

Earnings for Palomar are expected to grow by 15.63% in the coming year, from $9.02 to $10.43 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Palomar is 15.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.03.

Price to Earnings Ratio vs. Sector

The P/E ratio of Palomar is 15.86, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 23.96.

Price to Book Value per Share Ratio

Palomar has a P/B Ratio of 3.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.65% of the float of Palomar has been sold short.

Short Interest Ratio / Days to Cover

Palomar has a short interest ratio ("days to cover") of 3.28, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Palomar has recently increased by 3.80%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Palomar does not currently pay a dividend.

Dividend Growth

Palomar does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.59

News Sentiment

Palomar has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Palomar this week, compared to 6 articles on an average week.

Search Interest

Only 3 people have searched for PLMR on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Palomar insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,318,111.00 in company stock.

Percentage Held by Insiders

3.70% of the stock of Palomar is held by insiders.

Percentage Held by Institutions

90.25% of the stock of Palomar is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/06/2026
• Today: 5/25/2026
• Next Earnings (Estimated): 8/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: INS - PROP&CASLTY
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:PLMR
• CIK: 1761312
• Web: www.palomarspecialty.com
• Phone: (619) 567-5290
• Fax: 619-567-6954
• Employees: 150
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Palomar: $150.25
• High Price Target: $160.00
• Low Price Target: $132.00
• Potential Upside/Downside: +31.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $7.18
• Trailing P/E Ratio: 15.86
• Forward P/E Ratio: 12.62
• P/E Growth: N/A
• Net Income: $197.07 million
• Net Margins: 20.11%
• Pretax Margin: 25.82%
• Return on Equity: 22.62%
• Return on Assets: 6.60%

Debt

• Debt-to-Equity Ratio: 0.31
• Current Ratio: 0.49
• Quick Ratio: 0.49

Sales & Book Value

• Annual Sales: $875.97 million
• Price / Sales: 3.44
• Cash Flow: $7.78 per share
• Price / Cash Flow: 14.64
• Book Value: $36.19 per share
• Price / Book: 3.15

Miscellaneous

• Outstanding Shares: 26,500,000
• Free Float: 25,523,000
• Market Cap: $3.02 billion
• Optionable: Optionable
• Beta: 0.49